Success Metrics

Clinical Success Rate
70.8%

Based on 17 completed trials

Completion Rate
71%(17/24)
Active Trials
1(3%)
Results Posted
35%(6 trials)
Terminated
7(18%)

Phase Distribution

Ph early_phase_1
3
8%
Ph phase_3
3
8%
Ph not_applicable
13
34%
Ph phase_4
6
16%
Ph phase_2
9
24%
Ph phase_1
3
8%

Phase Distribution

6

Early Stage

9

Mid Stage

9

Late Stage

Phase Distribution37 total trials
Early Phase 1First-in-human
3(8.1%)
Phase 1Safety & dosage
3(8.1%)
Phase 2Efficacy & side effects
9(24.3%)
Phase 3Large-scale testing
3(8.1%)
Phase 4Post-market surveillance
6(16.2%)
N/ANon-phased studies
13(35.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.8%

17 of 24 finished

Non-Completion Rate

29.2%

7 ended early

Currently Active

1

trials recruiting

Total Trials

38

all time

Status Distribution
Active(1)
Completed(17)
Terminated(7)
Other(13)

Detailed Status

Completed17
unknown13
Terminated7
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
38
Active
1
Success Rate
70.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (8.1%)
Phase 13 (8.1%)
Phase 29 (24.3%)
Phase 33 (8.1%)
Phase 46 (16.2%)
N/A13 (35.1%)

Trials by Status

completed1745%
terminated718%
unknown1334%
recruiting13%

Recent Activity

1 active trials
Showing 5 of 38
recruitingphase_4

The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis

NCT06609447
completednot_applicable

Modulation of Type 1 Diabetes Susceptibility Through the Use of Probiotics

NCT03423589
completedearly_phase_1

Impact of Probiotics on Oral Microbiota in Older Adults With Dysphagia

NCT03682094
unknownnot_applicable

VSL#3® vs Placebo in the Treatment of Fatigue and Other Symptoms in Long Covid (DELong#3)

NCT05874089
terminatedphase_1

Safety of VSL#3 in Adult Asthmatics

NCT00852124
View all 38 trials

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT06609447Phase 4

The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis

Recruiting
NCT03423589Not Applicable

Modulation of Type 1 Diabetes Susceptibility Through the Use of Probiotics

Completed
NCT03682094Early Phase 1

Impact of Probiotics on Oral Microbiota in Older Adults With Dysphagia

Completed
NCT05874089Not Applicable

VSL#3® vs Placebo in the Treatment of Fatigue and Other Symptoms in Long Covid (DELong#3)

Unknown
NCT00852124Phase 1

Safety of VSL#3 in Adult Asthmatics

Terminated
NCT05608928Phase 2

Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia

Unknown
NCT03092427Not Applicable

Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)

Unknown
NCT01635192Early Phase 1

Effects of Probiotic VSL#3 on Expression of Small Intestinal Renin-angiotensin System

Completed
NCT04256785Not Applicable

Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to Fibromyalgia

Completed
NCT03586622Not Applicable

One Year Home Monitoring and Treatment of IBS Patients

Unknown
NCT03165747Phase 2

Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women

Terminated
NCT03415711Not Applicable

PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis

Terminated
NCT00179582Not Applicable

Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS

Terminated
NCT02011542Phase 2

Probiotic (VSL #3) for Gulf War Illness

Terminated
NCT03078530Phase 2

Probiotic (Visbiome) for Gulf War Illness

Unknown
NCT03115385Not Applicable

Probiotics and the Gut Microbiome in Obese Hispanic Youth

Terminated
NCT00831337Not Applicable

Evaluation of Probiotics in the Treatment of Portal Hypertension

Completed
NCT00630838Phase 2

Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)

Completed
NCT00933556Phase 2

A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE

Completed
NCT01877967Not Applicable

Investigating the Effect of Dietary Supplement VSL#3 on Cognition and Mood in Healthy Older Adults

Unknown

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
38